FDA says comparator dose scuppered Moderna's flu jab filing
The FDA has defended its decision to issue a refusal-to-file (RTF) letter for Moderna's new mRNA-based influenza vaccine.
Newsletters and Deep Dive digital magazine
The FDA has defended its decision to issue a refusal-to-file (RTF) letter for Moderna's new mRNA-based influenza vaccine.
The board at Sanofi has said it will not renew CEO Paul Hudson's contract, and has turned to former Merck CEO Belén Garijo to lead the group.
As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
More than half of clinicians polled about digital pharma communications have said they tend to be over-promotional and not helpful.
Novo Nordisk has been criticised by the FDA for a TV ad for the Wegovy pill, which the agency claims makes "false and misleading" claims.
Editor's Picks
Newsletters and Deep Dive
digital magazine